SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH)

36 filings reported holding SOPH - SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share as of Q3 2024.
SOPHiA GENETICS SA - Ordinary Shares, par value CHF 0.05 per share (SOPH) has 30 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 17.9M shares of 66.4M outstanding shares and own 26.91% of the company stock.
Largest 10 shareholders include GENERATION INVESTMENT MANAGEMENT LLP (6.79M shares), BANQUE PICTET & CIE SA (2.24M shares), AKRE CAPITAL MANAGEMENT LLC (2.24M shares), UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (2.22M shares), PRINCIPAL FINANCIAL GROUP INC (1.46M shares), Alta Wealth Advisors LLC (1.41M shares), MILLENNIUM MANAGEMENT LLC (656K shares), Bank Pictet & Cie (Europe) AG (223K shares), EDMOND DE ROTHSCHILD HOLDING S.A. (203K shares), and GEODE CAPITAL MANAGEMENT, LLC (89.5K shares).
This table shows the top 30 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.